Search

Author/Creator Tsai, Hsiang‐i

1. Engineered Small Extracellular Vesicles as a FGL1/PD‐L1 Dual‐Targeting Delivery System for Alleviating Immune Rejection (Adv. Sci. 3/2022). Issue 3 (25th January 2022)

Authors:
Tsai, Hsiang‐i; Wu, Yingyi; Liu, Xiaoyan; Xu, Zhanxue; Liu, Longshan; Wang, Changxi; Zhang, Huanxi; Huang, Yisheng; Wang, Linglu; Zhang, Weixian; Su, Dandan; Khan, Fahim Ullah; Zhu, Xiaofeng; Yang, Rongya; Pang, Yuxin; Eriksson, John E.; Zhu, Haitao; Wang, Dongqing; Jia, Bo; Cheng, Fang
Journal:
Advanced science
Issue:
Volume 9:Issue 3(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Engineered Small Extracellular Vesicles as a FGL1/PD‐L1 Dual‐Targeting Delivery System for Alleviating Immune Rejection. Issue 3 (5th November 2021)

Authors:
Tsai, Hsiang‐i; Wu, Yingyi; Liu, Xiaoyan; Xu, Zhanxue; Liu, Longshan; Wang, Changxi; Zhang, Huanxi; Huang, Yisheng; Wang, Linglu; Zhang, Weixian; Su, Dandan; Khan, Fahim Ullah; Zhu, Xiaofeng; Yang, Rongya; Pang, Yuxin; Eriksson, John E.; Zhu, Haitao; Wang, Dongqing; Jia, Bo; Cheng, Fang
Journal:
Advanced science
Issue:
Volume 9:Issue 3(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development. Issue 3 (8th February 2021)

Authors:
Tsai, Hsiang‐i; Zeng, Xiaobin; Liu, Longshan; Xin, Shengchang; Wu, Yingyi; Xu, Zhanxue; Zhang, Huanxi; Liu, Gan; Bi, Zirong; Su, Dandan; Yang, Min; Tao, Yijing; Wang, Changxi; Zhao, Jing; Eriksson, John E; Deng, Wenbin; Cheng, Fang; Chen, Hongbo
Journal:
EMBO molecular medicine
Issue:
Volume 13:Issue 3(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search